Dr. Reddy's Laboratories LimitedRDYNYSE
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
3.04%
↓ 100% below average
Average (39q)
1520.60%
Historical baseline
Range
High:8701.51%
Low:-98.87%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 3.04% |
| Q2 2025 | 0.46% |
| Q1 2025 | 1.76% |
| Q4 2024 | 4.27% |
| Q3 2024 | 4.48% |
| Q2 2024 | 8.33% |
| Q1 2024 | -1.83% |
| Q4 2023 | 8569.56% |
| Q3 2023 | -98.76% |
| Q2 2023 | 8701.51% |
| Q1 2023 | -98.87% |
| Q4 2022 | 8468.45% |
| Q3 2022 | -98.49% |
| Q2 2022 | 7117.68% |
| Q1 2022 | -98.64% |
| Q4 2021 | 6738.92% |
| Q3 2021 | -98.42% |
| Q2 2021 | 7483.77% |
| Q1 2021 | -98.68% |
| Q4 2020 | 7387.41% |
| Q3 2020 | -98.51% |
| Q2 2020 | -0.32% |
| Q1 2020 | 7101.07% |
| Q4 2019 | -98.72% |
| Q3 2019 | 24.91% |
| Q2 2019 | -4.31% |
| Q1 2019 | 4.33% |
| Q4 2018 | 1.37% |
| Q3 2018 | 2.07% |
| Q2 2018 | 5.26% |
| Q1 2018 | -7.12% |
| Q4 2017 | 7.33% |
| Q3 2017 | 6.94% |
| Q2 2017 | -6.70% |
| Q1 2017 | -4.11% |
| Q4 2016 | 3.37% |
| Q3 2016 | 10.86% |
| Q2 2016 | -13.89% |
| Q1 2016 | -5.34% |
| Q4 2015 | -0.53% |